Wei Lin sold RVMD
March 17, 2026 · Form 4 insider transaction
Wei Lin sold 2,073 shares of Revolution Medicines, Inc. at $99.48 per share, a transaction worth $206.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,073
Price
$99.48
Total value
$206.2K
InsiderWei Lin
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 17, 2026
Filing dateMarch 19, 2026
Shares owned after101,366
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on December 23, 2024 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after March 15, 2025.; Includes 62,050 RSUs.